COMMUNIQUÉS West-GlobeNewswire

-
Shire plc : Rule 2.9 Announcement
24/05/2018 -
Saniona publishes its interim report for the first quarter 2018
24/05/2018 -
Bavarian Nordic Announces Interim Results for the First Three Months of 2018
24/05/2018 -
Sandoz receives European Commission approval for Zessly® (infliximab) in gastroenterological, rheumatological and dermatological diseases
24/05/2018 -
Scholar Rock Announces Pricing of Initial Public Offering
24/05/2018 -
Arcturus Therapeutics Comments on Court Ruling on Undisclosed Group Organized by Joseph E. Payne and his Associates in Violation of Regulation 13D
24/05/2018 -
Kiniksa Pharmaceuticals, Ltd. Announces Pricing of Initial Public Offering
24/05/2018 -
Melinta Therapeutics Announces Pricing of Public Offering of Common Stock
24/05/2018 -
Allscripts to deliver anesthesia solution across SingHealth healthcare institutions
24/05/2018 -
Adventist Health Appoints Rick Rawson as President of Rideout Health
24/05/2018 -
Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine
23/05/2018 -
Cytori Therapeutic’s common stock to begin trading on adjusted basis on May 24, following one-for-ten reverse split
23/05/2018 -
Amarin to Present at the Jefferies Global Healthcare Conference
23/05/2018 -
Retrophin Receives Workplace Excellence Award
23/05/2018 -
The Cooper Companies Announces Executive Management Changes
23/05/2018 -
Myriad Announces Seven New Payer Coverage Decisions for Prolaris®
23/05/2018 -
Tonix Pharmaceuticals to Present at the 2018 American Society of Clinical Psychopharmacology
23/05/2018 -
Thetis Pharmaceuticals Receives $1.9 Million Fast-Track NIH Grant to Advance Novel Inflammatory Bowel Disease Drug Pipeline Toward Clinical Investigation
23/05/2018 -
Integra LifeSciences to Present at Healthcare Conferences in June 2018
23/05/2018
Pages